Results 291 to 300 of about 4,530,344 (319)
Some of the next articles are maybe not open access.
The lung microbiome in lung transplantation
The Journal of Heart and Lung Transplantation, 2021Culture-independent study of the lower respiratory tract after lung transplantation has enabled an understanding of the microbiome - that is, the collection of bacteria, fungi, and viruses, and their respective gene complement - in this niche. The lung has unique features as a microbial environment, with balanced entry from the upper respiratory tract,
Joshua M. Diamond+6 more
openaire +3 more sources
Respiration Physiology, 1995
In the lung, nitric oxide (NO) derives from several cellular sources, forming networks of paracrine communication. In pulmonary vessels, NO produced by endothelial cells is a powerful vasodilator. In the airways, NO originates from epithelial cells and from adventitial nerve endings to induce smooth muscle relaxation.
Bernadette Raffestin+2 more
openaire +3 more sources
In the lung, nitric oxide (NO) derives from several cellular sources, forming networks of paracrine communication. In pulmonary vessels, NO produced by endothelial cells is a powerful vasodilator. In the airways, NO originates from epithelial cells and from adventitial nerve endings to induce smooth muscle relaxation.
Bernadette Raffestin+2 more
openaire +3 more sources
Archives of Surgery, 1941
Until relatively recently the diagnosis of cancer of the lung inevitably signified a rapidly tragic outcome. Within the past six years, however, many patients with pulmonary malignant tumor have been spared this death sentence by the successful removal of the cancerous lung. Of even greater importance is the increasing incidence of such survivals.
Alton Ochsner+4 more
openaire +7 more sources
Until relatively recently the diagnosis of cancer of the lung inevitably signified a rapidly tragic outcome. Within the past six years, however, many patients with pulmonary malignant tumor have been spared this death sentence by the successful removal of the cancerous lung. Of even greater importance is the increasing incidence of such survivals.
Alton Ochsner+4 more
openaire +7 more sources
The Annals of Thoracic Surgery, 2001
Better understanding of the mechanisms of ischemia-reperfusion injury, improvement in the technique of lung preservation, and the recent introduction of a new preservation solution specifically developed for the lungs have helped to reduce the incidence of primary graft dysfunction after lung transplantation.
Keshavjee S, de Perrot M
openaire +5 more sources
Better understanding of the mechanisms of ischemia-reperfusion injury, improvement in the technique of lung preservation, and the recent introduction of a new preservation solution specifically developed for the lungs have helped to reduce the incidence of primary graft dysfunction after lung transplantation.
Keshavjee S, de Perrot M
openaire +5 more sources
Lung and heart-lung transplantation [PDF]
This report is a brief summary on current events related to lung and heart-lung transplantation. Eleven patients have undergone transplantation of the heart and both lungs at Stanford University. The ages ranged from 22-45, the average age being about 36 years, and included were four females and seven males.
openaire +2 more sources
Lung Cancer and Lung Transplantation
Thoracic Surgery Clinics, 2018Lung transplantation remains a viable option for patients with endstage pulmonary disease. Despite removing the affected organ and replacing both lungs, the risk of lung malignancies still exists. Regardless of the mode of entry, lung cancer affects the prognosis in these patients and diligence is required.
Benjamin E. Haithcock, Timothy Brand
openaire +3 more sources
Nursing Standard, 2015
Living Lung is a real-time, three-dimensional medical education and patient communication tool that features detailed, colour, anatomical respiratory models.
openaire +3 more sources
Living Lung is a real-time, three-dimensional medical education and patient communication tool that features detailed, colour, anatomical respiratory models.
openaire +3 more sources
Cancer chemotherapy and biological response modifiers, 1990
In small cell lung cancer (SCLC) combination chemotherapy including agents such as etoposide, teniposide, cisplatinum, carboplatin, and vincristine, doxorubicin, and cyclophosphamide, or ifosfamide continues to be the back-bone of therapy. The epipodophyllotoxin derivatives together with cisplatin or carboplatin are being used increasingly as part of ...
H H, Hansen, M, Rørth
openaire +10 more sources
In small cell lung cancer (SCLC) combination chemotherapy including agents such as etoposide, teniposide, cisplatinum, carboplatin, and vincristine, doxorubicin, and cyclophosphamide, or ifosfamide continues to be the back-bone of therapy. The epipodophyllotoxin derivatives together with cisplatin or carboplatin are being used increasingly as part of ...
H H, Hansen, M, Rørth
openaire +10 more sources